Lytix Biopharma AS announces that an abstract on LTX-315 in combination with ... - PR Newswire

Retrieved on: 2022-05-27 18:22:18

Tags for this article:

Click the tags to see associated articles and topics

Lytix Biopharma AS announces that an abstract on LTX-315 in combination with ... - PR Newswire. View article details on hiswai:

Excerpt

PRNewswire/ -- Lytix Biopharma AS ("Lytix" or the "Company"), a clinical-stage company with an in situ vaccination technology platform, ...

Article found on: www.prnewswire.com